Pulse Biosciences, Inc. Increase (Decrease) in Other Receivables
Pulse Biosciences, Inc. (PLSE) reported Increase (Decrease) in Other Receivables of $14.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2025-11-05
- Pulse Biosciences, Inc. increase (decrease) in other receivables for the quarter ending 2025-09-30 was $0.00.
- Pulse Biosciences, Inc. increase (decrease) in other receivables for the quarter ending 2025-06-30 was $7.00K.
- Pulse Biosciences, Inc. increase (decrease) in other receivables for the quarter ending 2025-03-31 was $7.00K, a 0.00% change year-over-year.
- Pulse Biosciences, Inc. increase (decrease) in other receivables for the quarter ending 2024-12-31 was -$41.00K, a 920.00% decline year-over-year.
- Pulse Biosciences, Inc. increase (decrease) in other receivables for fiscal 2024 was -$48.00K.
- Pulse Biosciences, Inc. increase (decrease) in other receivables for fiscal 2023 was -$109.00K, a 365.85% decline from fiscal 2022.
- Pulse Biosciences, Inc. increase (decrease) in other receivables for fiscal 2022 was $41.00K.
- Pulse Biosciences, Inc. increase (decrease) in other receivables for fiscal 2021 was -$54.00K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $7.00K derived: sum of 2 quarters · filed 2025-11-05 | $14.00K 10-Q · filed 2025-11-05 | -$27.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $14.00K 10-Q · filed 2025-08-12 | -$27.00K derived: sum of 3 quarters · filed 2025-08-12 | -$31.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-03-31 | $7.00K 10-Q · filed 2025-05-08 | -$34.00K derived: sum of 2 quarters · filed 2025-05-08 | -$38.00K derived: sum of 3 quarters · filed 2025-11-05 | -$48.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-12-31 | -$41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$45.00K derived: sum of 2 quarters · filed 2025-11-05 | -$55.00K derived: sum of 3 quarters · filed 2025-11-05 | -$48.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$14.00K derived: sum of 2 quarters · filed 2025-11-05 | -$7.00K 10-Q · filed 2025-11-05 | -$2.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$3.00K 10-Q · filed 2025-08-12 | $2.00K derived: sum of 3 quarters · filed 2025-08-12 | -$6.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $7.00K 10-Q · filed 2025-05-08 | $12.00K derived: sum of 2 quarters · filed 2025-05-08 | $4.00K derived: sum of 3 quarters · filed 2025-05-08 | -$103.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$3.00K derived: sum of 2 quarters · filed 2025-03-31 | -$110.00K derived: sum of 3 quarters · filed 2025-03-31 | -$109.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$115.00K derived: sum of 2 quarters · filed 2024-10-30 | -$114.00K 10-Q · filed 2024-10-30 | -$126.00K derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | -$107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | -$106.00K 10-Q · filed 2024-08-19 | -$118.00K derived: sum of 3 quarters · filed 2024-08-19 | -$95.00K derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $1.00K 10-Q · filed 2024-05-07 | -$11.00K derived: sum of 2 quarters · filed 2024-05-07 | $12.00K derived: sum of 3 quarters · filed 2024-05-07 | $3.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $11.00K derived: sum of 2 quarters · filed 2024-03-28 | $2.00K derived: sum of 3 quarters · filed 2024-03-28 | $41.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $14.00K derived: sum of 2 quarters · filed 2023-11-13 | $53.00K 10-Q · filed 2023-11-13 | $31.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $30.00K 10-Q · filed 2023-08-10 | $8.00K derived: sum of 3 quarters · filed 2023-08-10 | -$1.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $39.00K 10-Q · filed 2023-05-11 | $17.00K derived: sum of 2 quarters · filed 2023-05-11 | $8.00K derived: sum of 3 quarters · filed 2023-05-11 | $33.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$31.00K derived: sum of 2 quarters · filed 2023-03-31 | -$6.00K derived: sum of 3 quarters · filed 2023-03-31 | -$54.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $16.00K derived: sum of 2 quarters · filed 2022-11-10 | -$32.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$23.00K 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | -$48.00K 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |